Medtronic PLC (MDT) Dividend Stock Analysis


Medtronic PLC (NYSE:MDT) manufactures and sells device-based medical therapies worldwide. This dividend champion has paid dividends since 1977 and increased them for 39 years in a row.

The company’s last dividend increase was in June 2016 when the Board of Directors approved a 13.10% increase (1) to 43 cents/share. The company’s largest competitors include Baxter International Inc (NYSE:BAX), Becton Dickinson and Co (NYSE:BDX) and St Jude Medical Inc (NYSE:STJ).

Over the past decade this dividend growth stock (2) has delivered an annualized total return of 5% to its shareholders.




Comments